MCT6, designated scientifically as SLC16A6, is a protein encoded by the SLC16A6 gene in humans and is part of the solute carrier family 16. As a member of this family, MCT6 is presumed to be a transporter protein that specializes in the transmembrane movement of monocarboxylic acids, which are crucial metabolic intermediates in the body's energy economy. Monocarboxylic acids such as lactate, pyruvate, and ketone bodies are key substances that are shuttled across cell membranes to maintain metabolic homeostasis, especially in tissues with high energy demands or under metabolic stress. The expression and functional regulation of MCT6 are important for the efficient transport of these molecules, and its activity is hypothesized to be modulated by various biochemical and physiological conditions within the body. As an integral component of the plasma membrane, MCT6 plays a pivotal role in the cellular uptake and release of these acids, and thus, factors that can upregulate its expression are of considerable interest in the study of cellular metabolism.
Potential activators of MCT6 expression include a variety of chemical compounds that are central to cellular metabolic pathways. Compounds such as butyrate and its derivatives, which are short-chain fatty acids produced through the fermentation of dietary fibers in the gut, may upregulate MCT6 to facilitate their own transport across the intestinal epithelium. Nicotinamide, a form of vitamin B3, could also serve as an activator, given its role in redox reactions and potential to stimulate pathways that require monocarboxylate transport. Similarly, molecules like retinoic acid and hydrocortisone are known to mediate gene expression through their interactions with nuclear receptors, which could lead to an upsurge in MCT6 transcription to adjust to the metabolic needs dictated by growth, differentiation, or stress responses. Moreover, signaling molecules such as forskolin, which increases intracellular cAMP levels, might promote the expression of MCT6, potentially enhancing the cellular response to hormonal stimulation and energy balance. The precise mechanisms by which these compounds might stimulate MCT6 expression are yet to be elucidated, and further research is essential to understand the complex regulatory networks that control this transporter's activity.
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $43.00 $65.00 $200.00 $815.00 | 6 | |
Nicotinamide, as a vitamin B3 derivative, could stimulate MCT6 expression to facilitate metabolic reactions involving monocarboxylates. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid, through its role in gene transcription, may specifically increase MCT6 expression to adjust cellular uptake of monocarboxylates. | ||||||
Hydrocortisone | 50-23-7 | sc-300810 | 5 g | $100.00 | 6 | |
Hydrocortisone could enhance MCT6 expression as part of the adaptive response to stress, altering monocarboxylate metabolism. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin may stimulate MCT6 expression by elevating cAMP levels, which could trigger a signaling cascade promoting MCT6 transcription. | ||||||
1α,25-Dihydroxyvitamin D3 | 32222-06-3 | sc-202877B sc-202877A sc-202877C sc-202877D sc-202877 | 50 µg 1 mg 5 mg 10 mg 100 µg | $325.00 $632.00 $1428.00 $2450.00 $400.00 | 32 | |
This active metabolite of vitamin D could specifically induce MCT6 expression to manage the transport of monocarboxylates in calcium and phosphate metabolism. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $153.00 $1224.00 $12239.00 | 82 | |
Insulin might upregulate MCT6 expression to maintain glucose homeostasis by modulating the uptake of monocarboxylates. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $77.00 | 2 | |
Metformin may stimulate the expression of MCT6 as a part of its action to enhance glucose utilization and fatty acid oxidation. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $62.00 $178.00 | 8 | |
β-Estradiol could increase the transcription of MCT6, potentially as a mechanism to adjust energy substrate utilization during different phases of the menstrual cycle. | ||||||
L-Thyroxine, free acid | 51-48-9 | sc-207813 sc-207813A | 100 mg 500 mg | $34.00 $73.00 | 2 | |
Thyroxine could upregulate MCT6 expression to stimulate basal metabolic rate by enhancing the transport of energy substrates. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Sodium butyrate may induce MCT6 expression by serving as a histone deacetylase inhibitor, altering chromatin structure and gene expression. |